Experts against booster shot, mixing vaccine brands | Inquirer News

Experts against booster shot, mixing vaccine brands

/ 04:52 AM August 02, 2021
Judiciary still determining completion date for COVID vaccination

FILE PHOTO: Vials labelled “AstraZeneca, Pfizer – Biontech, Johnson&Johnson, Sputnik V coronavirus disease (COVID-19) vaccine” are seen in this illustration picture taken May 2, 2021. REUTERS/Dado Ruvic/Illustration/File Photo

MANILA, Philippines — Philippine Society for Microbiology and Infectious Diseases (PSMID) has recommended against giving a booster shot of the COVID-19 vaccine as well as mixing brands, citing a “paucity of evidence” to support such possible changes in the current policies.

An infectious diseases specialist from Israel also gave a similar advice to the Philippine government, following a five-day visit to discuss the pandemic response.


Dr. Guy Choshen of Tel Aviv Sourasky Medical Center said a third dose was irrelevant when the Philippines had inoculated only a small portion of its population, so far.

“My advice is to first, vaccinate with the first dose and the second dose of whatever [vaccine] you have and wait with this question for a later stage when most of the population [has been] vaccinated … The question of a third or booster vaccine is irrelevant at the moment …,” Choshen said in a press conference on Friday.


The Israeli doctor offered the same recommendation for Filipino senior citizens, who are among the “special population” that local experts said would likely require a booster, following reports of waning immunity.

The Vaccine Expert Panel is expected to come out with a position on boosters, targeting the immunocompromised, such as the elderly, transplant patients and HIV-positive individuals.

In a statement on Sunday, PSMID said: “The need for and timing for COVID-19 booster doses has not been proven. Fully vaccinated individuals do not need a booster shot at this time. There is currently a paucity of evidence to support recommendations for a COVID-19 vaccine booster shot for the general population.”

On heterologous vaccination or mixing brands in the two-dose series: “We suggest that the primary series of COVID-19 vaccines be completed as recommended using the same product at the prescribed interval. There is currently insufficient data on using a different vaccine from that first dose to complete a primary series,” it said.

PSMID said it awaited the results of vaccine mix and match studies.

It said the evolving concerns with vaccine effectiveness stemmed from threats of newer SARS-CoV-2 variants and the risk of waning immunity after inoculation.

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: covid-19 vaccination, COVID-19 vaccine booster shot, PSMID
For feedback, complaints, or inquiries, contact us.

News that matters

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.

© Copyright 1997-2021 | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.